トップページ - 自治医科大学

Risk-Adapted Letermovir Prophylaxis Based on a Scoring System Predicting a Higher Burden of Cytomegalovirus Exposure After Allogeneic Hematopoietic Cell Transplantation

Kawamura S, Fujiwara S, Kimura S, Takeshita J, Nakasone H, Yoshimura K, Nakata Y, Ishikawa T, Matsuoka A, Meno T, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Gomyo A, Kusuda M, Murahashi R, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kako S, Kanda Y

Transplant Cell Ther 31 184.e1-184.e11 2025年査読有り

Rapid tapering of cyclosporine after allogeneic transplantation for high-risk hematological malignancies

Gomyo A, Kako S, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Kimura S, Nakasone H, Kanda Y

Int J Hematol 121 504-510 2025年査読有り

Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation

Yoshimura K, Nakasone H, Tamaki M, Hosoi H, Kameda K, Uchida N, Doki N, Fukuda T, Yoshihara S, Mori Y, Nakamae H, Tanaka M, Katayama Y, Eto T, Hasegawa Y, Ota S, Takahashi S, Yoshimitsu M, Ishimaru F, Kanda J, Atsuta Y, Yakushijin K

Am J Hematol 100 1185-1195 2025年査読有り

Fatal pneumonia with repeated detection of Talaromyces columbinus two years after haploidentical transplantation

Nakata Y, Yoshino N, Kusuda M, Kimura S, Matsuoka A, Meno T, Ishikawa T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Misaki Y, Yoshimura K, Gomyo A, Tamaki M, Hoshino Y, Shinohara T, Miyazaki Y, Nakasone H, Kako S, Kanda Y

J Infect Chemother 31 102649 2025年査読有り

Clinical impact of a change in antibiotics or the addition of glycopeptide antibiotics for persistent febrile neutropenia after autologous stem cell transplantation

Yoshino N, Kimura S, Kawamura K, Nakata Y, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Tamaki M, Kusuda M, Kameda K, Akahoshi Y, Sato M, Tanihara A, Nakasone H, Kako S, Kanda Y

J Infect Chemother 31 102455 2025年査読有り

A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors

Shimomura Y, Komukai S, Kitamura T, Yoshimura K, Inamoto Y, Akahoshi Y, Kuwatsuka Y, Usui Y, Uchida N, Tanaka M, Onizuka M, Sakata-Yanagimoto M, Doki N, Hasegawa Y, Ishiwata K, Nakamae H, Sawa M, Katayama Y, Kawakita T, Yoshimitsu M, Fukuda T, Kanda Y, Ohbiki M, Nakasone H, Kanda J

Br J Haematol 207 946-955 2025年査読有り

Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib era

Okada Y, Nakasone H, Kawamura S, Takano K, Yoshimura K, Tamaki M, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Takeshita J, Yoshino N, Misaki Y, Kusuda M, Tanihara A, Kimura S, Kako S, Kanda Y

Haematologica 109 3593-3601 2024年査読有り

Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation

Matsumi S, Kimura S, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Tanihara A, Sato M, Nakasone H, Kako S, Kanda Y

Int J Hematol 118 450-461 2023年査読有り

Secondary Budd-Chiari syndrome caused by adult T-cell leukemia/lymphoma

Tominaga R, Yoshimura K, Kawamura M, Kako S, Kanda Y, Morikawa H, Ando S, Okabe N, Hiruta M, Tanaka A, Oshiro H

Pathol Int 73 520-522 2023年査読有り

Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation

Okada Y, Nakasone H, Yoshimura K, Tamaki M, Kusuda M, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Gomyo A, Tanihara A, Kimura S-I, Kako S, Kanda Y

Int J Hematol 118 340-346 2023年査読有り

Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients

Kusuda M, Nakasone H, Yoshimura K, Okada Y, Tamaki M, Matsuoka A, Ishikawa T, Meno T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Gomyo A, Tanihara A, Kimura S, Kako S, Kanda Y

Br J Haematol 202 578-588 2023年査読有り

Clinical Impact of Pretransplantation Physical Function on Transplantation after Allogeneic Hematopoietic Cell Transplantation in Older Adults

Gomyo A, Kimura S, Suzuki J, Ishikawa T, Meno T, Matsuoka A, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Sekine K, Nakasone H, Kako S, Kanda Y

Transplant Cell Ther 29 721.e1-721.e8 2023年査読有り

Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia

Yoshino N, Kimura S, Matsuoka A, Meno T, Ishikawa T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Wada H, Nakasone H, Kako S, Kanda Y

J Infect Chemother 29 384-390 2023年査読有り

Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension

Misaki Y, Minakata D, Ibe T, Gomyo A, Yoshimura K, Kimura S, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Hatano K, Nakasone H, Imadome K, Wada H, Kako S, Oshiro H, Tanaka A, Kanda Y

J Infect Chemother 29 212-218 2023年査読有り

Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy

Nakamura Y, Kawamura S, Matsumi S, Matsumoto K, Tanaka S, Ishikawa T, Matsuoka A, Meno T, Kawamura M, Takeshita J, Yoshino N, Yoshimura K, Misaki Y, Gomyo A, Okada Y, Tamaki M, Kusuda M, Akahoshi Y, Kameda K, Wada H, Kimura S-I, Nakasone H, Kako S, Date H, Kanda Y

Rinsho Ketsueki Jpn J Clin Hematol 64 250-254 2023年査読有り

Very early death within 30 days after diagnosis in patients with acute myeloid leukemia

Kusuda M, Nakasone H, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Tamaki M, Kusuda M, Kameda K, Kimura S, Kako S, Kanda Y

Int J Hematol 117 198-205 2022年査読有り

Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation

Kawamura S, Tamaki M, Nakamura Y, Kawamura M, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Okada Y, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Kimura S, Nakasone H, Kako S, Kanda Y

Acta Haematol 145 553-559 2022年査読有り

Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

Tamaki M, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Okada Y, Kusuda M, Kameda K, Akahoshi Y, Kimura S, Kako S, Kanda Y

Leuk Lymphoma 63 2197-2205 2022年査読有り

Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation

Okada Y, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Tamaki M, Kusuda M, Kameda K, Kimura S, Kako S, Oyama-Manabe N, Kanda Y

J Gastroenterol 57 571-580 2022年査読有り

Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remission

Kimura S-I, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Nakasone H, Kako S, Kanda Y

Acta Haematol 145 404-411 2022年査読有り

Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host Disease

Yoshimura K, Kimura S-I, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Matsumi S, Gomyo A, Tanihara A, Okada Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kako S, Kanda Y

Transplant Cell Ther 28 597.e1-597.e9 2022年査読有り

Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation

Tamaki M, Matsumi S, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Okada Y, Kusuda M, Kameda K, Kimura S, Kako S, Kanda Y

Bone Marrow Transplant 57 1382-1388 2022年査読有り

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

Kimura S-I, Shimizu H, Miyazaki T, Sakurai M, Tanoue S, Kayamori K, Ohwada C, Yoshimura K, Nakasone H, Ohashi T, Shono K, Tachibana T, Hatano K, Okada K, Kimura Y, Seo S, Doki N, Tanaka M, Hatta Y, Takahashi S, Kanda Y, Therapy KSG for C

Bone Marrow Transplant 58 452-455 2022年査読有り

Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

Okada Y, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Kawamura T, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Tamaki M, Kimura S-I, Kobayashi S, Kako S, Kimura F, Kanda Y

Bone Marrow Transplant 57 810-816 2021年査読有り

Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation

Kawamura S, Nakasone H, Takeshita J, Kimura S-I, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Tamaki M, Kako S, Kanda Y

Transplant Cell Ther 27 683.e1-683.e7 2021年査読有り

Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Misaki Y, Kako S, Kawamura S, Takeshita J, Yoshino N, Yoshimura K, Gomyo A, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Kimura S-I, Nakasone H, Kishino K, Muroi K, Kanda Y

Intern Med (Tokyo, Jpn) 61 1887-1890 2021年査読有り

Immunity and Vaccination Against Measles, Mumps, and Rubella in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients

Kawamura K, Wada H, Nakasone H, Akahoshi Y, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tamaki M, Kusuda M, Kameda K, Sato M, Tanihara A, Kimura S, Kako S, Kanda Y

Transplant Cell Ther 27 436.e1-436.e8 2021年査読有り

Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation

Nakasone H, Kusuda M, Terasako-Saito K, Kawamura K, Akahoshi Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Yoshimura K, Misaki Y, Gomyo A, Kameda K, Tamaki M, Tanihara A, Kimura S, Kako S, Kanda Y

Commun Biol 4 1177 2021年査読有り

Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

Akahoshi Y, Nakasone H, Kusuda M, Kameda K, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Tamaki M, Kimura S-I, Kako S, Kanda Y

Int J Hematol 115 748-752 2021年査読有り

Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors

Yoshimura K, Kimura S, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Gomyo A, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Nakasone H, Kako S, Kanda Y

Int J Hematol 114 674-681 2021年査読有り

Body Weight Loss Before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients

Tamaki M, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Okada Y, Kusuda M, Kameda K, Akahoshi Y, Kimura S, Kako S, Kanda Y

Transplant Cell Ther 27 340.e1-340.e6 2021年査読有り

Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation

Takeshita J, Kimura S-I, Nakasone H, Kawamura S, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Sato M, Kako S, Kanda Y

Transpl Infect Dis : Off J Transplant Soc 23 e13715 2021年査読有り

Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation

Kimura S, Sato M, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Terasako-Saito K, Kikuchi M, Tanihara A, Nakasone H, Kako S, Kanda Y

Transpl Immunol 58 101262 2020年査読有り

Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic

Tamaki M, Nakasone H, Aikawa T, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Kusuda M, Akahoshi Y, Kimura S, Kako S, Oyama-Manabe N, Kanda Y

Biol Blood Marrow Transplant 26 2318-2322 2020年査読有り

Impact of neutropenia evaluated in terms of the D-index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation

Kimura S, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Terasako-Saito K, Tanihara A, Nakasone H, Kako S, Kanda Y

Transpl Infect Dis 22 e13409 2020年査読有り

Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes

Tamaki M, Nakasone H, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Kusuda M, Akahoshi Y, Kawamura K, Kimura S, Kako S, Kanda Y

Ann Hematol 99 1369-1376 2020年査読有り

Detection of T315I using digital polymerase chain reaction in allogeneic transplant recipients with Ph-positive acute lymphoblastic anemia in the dasatinib era

Akahoshi Y, Nakasone H, Kawamura K, Kusuda M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Tamaki M, Kimura S, Kako S, Kanda Y

Exp Hematol 81 60-67 2020年査読有り

Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia

Gomyo A, Nakasone H, Wada H, Kawamura S, Yoshino N, Takeshita J, Yoshimura K, Misaki Y, Tanihara A, Akahoshi Y, Kusuda M, Tamaki M, Kawamura K, Kimura S, Kako S, Kanda Y

Intern Med 59 2409-2414 2020年査読有り

Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation

Kimura S-I, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Terasako-Saito K, Tanihara A, Nakasone H, Kako S, Kanda Y

Transpl Infect Dis : Off J Transplant Soc 23 e13460 2020年査読有り

Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post-engraftment phase after allogeneic hematopoietic stem cell transplantation

Kimura S, Takeshita J, Kawamura M, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Nakasone H, Kako S, Kanda Y

Transpl Infect Dis 22 e13387 2020年査読有り

Updated Clinical Outcomes of Hematopoietic Stem Cell Transplantation Using Myeloablative Total Body Irradiation with Ovarian Shielding to Preserve Fertility

Ashizawa M, Akahoshi Y, Nakano H, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Kimura S, Nakasone H, Kako S, Akahane K, Wakatsuki M, Shirai K, Kanda Y

Biol Blood Marrow Transplant 25 2461-2467 2019年査読有り

Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT

Akahoshi Y, Nakasone H, Kawamura K, Kusuda M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Tamaki M, Kimura S-I, Kako S, Kanda Y

Blood Adv 3 3287-3296 2019年査読有り

Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans

Nakasone H, Kikuchi M, Kawamura K, Akahoshi Y, Sato M, Kawamura S, Yoshino N, Takeshita J, Yoshimura K, Misaki Y, Gomyo A, Tanihara A, Kusuda M, Tamaki M, Kimura S-I, Kako S, Kanda Y

Sci Rep 9 16499 2019年査読有り

Impact of the patient’s body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation

Misaki Y, Kimura S-I, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Yoshimura K, Gomyo A, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Nakasone H, Kako S, Kanda Y

Transpl Infect Dis : Off J Transplant Soc 22 e13270 2019年査読有り

Effect of Smoking on Outcomes of Allogeneic Transplantation: A Single-Center Analysis

Tamaki M, Nakasone H, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Kusuda M, Akahoshi Y, Kawamura K, Kimura S-I, Kako S, Kanda Y

Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 26 1131-1136 2019年査読有り

Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation

Kameda K, Kimura S, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Tamaki M, Kusuda M, Akahoshi Y, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Tanihara A, Wada H, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Kanda Y

Bone Marrow Transplant 54 707-716 2019年査読有り

Outcome of gastrointestinal graft-versus-host disease according to the treatment response

Tamaki M, Nakasone H, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Kusuda M, Akahoshi Y, Ishihara Y, Kawamura K, Tanihara A, Sato M, Terasako-Saito K, Kameda K, Wada H, Kikuchi M, Kimura S, Kako S, Kanda Y

Ann Hematol 97 1951-1960 2018年査読有り

Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success

Kawamura K, Nakasone H, Kurosawa S, Yoshimura K, Misaki Y, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Wada H, Ishihara Y, Sato M, Terasako-Saito K, Kikuchi M, Kimura S-I, Tanihara A, Kako S, Kanamori H, Mori T, Takahashi S, Taniguchi S, Atsuta Y, Kanda Y

Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 24 1521-1526 2017年査読有り

Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation

Kusuda M, Kimura S-I, Misaki Y, Yoshimura K, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Ugai T, Kameda K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Kako S, Tanihara A, Kanda Y

Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 24 1367-1371 2017年査読有り

吉村一樹

基本情報

研究分野

経歴

学歴

論文

吉村 一樹

基本情報

研究分野

経歴

学歴

論文

吉村一樹